| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 8 789-799, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
DJ Satterwhite, ME Aakre, AE Gorska and HL Moses
Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
The concept of positive and negative regulation of normal cellular growth by diffusible factors is well illustrated by the effects of epidermal growth factor and transforming growth factor beta 1 (TGF beta 1) on mouse keratinocytes (MK) and mink lung epithelial cells (Mv1Lu). MK and Mv1Lu are nontransformed cell lines that reversibly arrest at a point in late G1 in response to TGF beta 1. Previously, we have shown that expression of the protooncogene c-myc is induced upon epidermal growth factor stimulation of quiescent MK and Mv1Lu cells and that transcriptional suppression of c-myc by TGF beta 1 treatment is important in the TGF beta 1 growth inhibition pathway. Using epidermal growth factor-stimulated synchronized MK and Mv1Lu cells, we have investigated the mRNA expression of a large number of growth factor-inducible genes that are critical regulators of growth in G1 and at the G1/S transition. These genes, often found to be dysregulated in cancer, include transcription factors as well as cyclins and their associated kinases, that promote growth, and tumor suppressor genes, that inhibit growth. As reported here, TGF beta 1 significantly inhibited mRNA expression of B-myb and cyclin A in both cell lines, suggesting that these may be important common downstream targets in the growth inhibition pathway. In contrast, the expression patterns of cyclins D1 and D2 and the transcription factors E2F1 and E2F2 were unaffected in MK cells treated with TGF beta 1 but were significantly inhibited in TGF beta 1-treated Mv1Lu cells. We cite the evidence suggesting that the inhibition of B-myb and cyclin A may contribute to the late G1 arrest caused by TGF beta 1 and that these events may be linked through the actions of the product of the retinoblastoma susceptibility gene (Rb) or an Rb family member.
This article has been cited by other articles:
![]() |
J. Gong, S. Ammanamanchi, T. C. Ko, and M. G. Brattain Transforming Growth Factor {beta}1 Increases the Stability of p21/WAF1/CIP1 Protein and Inhibits CDK2 Kinase Activity in Human Colon Carcinoma FET Cells Cancer Res., June 15, 2003; 63(12): 3340 - 3346. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Lee, B.-C. Kim, I. Y. Kim, E.-a. Cho, D. J. Satterwhite, and S.-J. Kim The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-beta Signaling by Blocking Binding of the Smad Complex to Its Target Sequence J. Biol. Chem., October 4, 2002; 277(41): 38557 - 38564. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kang, L. L. Ozbun, J. Angdisen, T. W. Moody, M. Prentice, B. A. Diwan, and S. B. Jakowlew Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-{beta}1 heterozygous mice Carcinogenesis, July 1, 2002; 23(7): 1217 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Dao, J. Hwa, and J. A. Nolta Molecular mechanism of transforming growth factor beta -mediated cell-cycle modulation in primary human CD34+ progenitors Blood, January 15, 2002; 99(2): 499 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakato, B. Fox, and S. B. Selleck dally, a Drosophila member of the glypican family of integral membrane proteoglycans, affects cell cycle progression and morphogenesis via a Cyclin A-mediated process J. Cell Sci., January 1, 2002; 115(1): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Satterwhite, R. L. White, N. Matsunami, and K. L. Neufeld Inhibition of Topoisomerase II{{alpha}} Expression by Transforming Growth Factor-{beta}1 Is Abrogated by the Papillomavirus E7 Protein Cancer Res., December 1, 2000; 60(24): 6989 - 6994. [Abstract] [Full Text] |
||||
![]() |
M. P. de Caestecker, E. Piek, and A. B. Roberts Role of Transforming Growth Factor-{beta} Signaling in Cancer J Natl Cancer Inst, September 6, 2000; 92(17): 1388 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. LANG, A. HARTNER, R. B. STERZEL, and H. O. SCHÖCKLMANN Requirement of Cyclin D1 in Mesangial Cell Mitogenesis J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1398 - 1408. [Abstract] [Full Text] |
||||
![]() |
R. C. Rancourt, R. J. Staversky, P. C. Keng, and M. A. O'reilly Hyperoxia inhibits proliferation of Mv1Lu epithelial cells independent of TGF-beta signaling Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1172 - L1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Choi, Y. W. Eom, Y. Kang, M. J. Ha, H. Rhee, J.-W. Yoon, and S.-J. Kim Cdc2 and Cdk2 Kinase Activated by Transforming Growth Factor-beta 1 Trigger Apoptosis through the Phosphorylation of Retinoblastoma Protein in FaO Hepatoma Cells J. Biol. Chem., November 5, 1999; 274(45): 31775 - 31783. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-S. Chang Hyaluronidase enhancement of TNF-mediated cell death is reversed by TGF-beta 1 Am J Physiol Cell Physiol, December 1, 1997; 273(6): C1987 - C1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshizumi, H. Wang, C.-M. Hsieh, N. E. S. Sibinga, M. A. Perrella, and M.-E. Lee Down-regulation of the Cyclin A Promoter by Transforming Growth Factor-beta 1 Is Associated with a Reduction in Phosphorylated Activating Transcription Factor-1 and Cyclic AMP-responsive Element-binding Protein J. Biol. Chem., August 29, 1997; 272(35): 22259 - 22264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sala, A. De Luca, A. Giordano, and C. Peschle The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity J. Biol. Chem., November 15, 1996; 271(46): 28738 - 28740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Hartsough, R. S. Frey, P. A. Zipfel, A. Buard, S. J. Cook, F. McCormick, and K. M. Mulder Altered Transforming Growth Factor beta Signaling in Epithelial Cells when Ras Activation Is Blocked J. Biol. Chem., September 13, 1996; 271(37): 22368 - 22375. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Feng, E. H. Filvaroff, and R. Derynck Transforming Growth Factor-beta (TGF-beta)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-beta Receptor Complex J. Biol. Chem., October 13, 1995; 270(41): 24237 - 24245. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Reynisdottir, K Polyak, A Iavarone, and J Massague Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes & Dev., August 1, 1995; 9(15): 1831 - 1845. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |